Literature DB >> 10714476

Importance of adjusting carbon monoxide diffusing capacity (DLCO) and carbon monoxide transfer coefficient (KCO) for alveolar volume.

D C Johnson1.   

Abstract

The volume dependence of single breath carbon monoxide diffusing capacity (DLCO) and carbon monoxide transfer coefficient (KCO) was determined in 24 healthy subjects. The change in DLCO [fraction of DLCO measured at total lung capacity (TLC)] to change in alveolar volume [fraction of alveolar volume (VA) at TLC] closely fitted a simple linear regression and matched a theoretical model. As VA decreased, DLCO fell linearly and KCO increased as expected from the relation of DLCO to VA. The equations for adjustment of predicted DLCO and KCO for alveolar volume are: DLCO/DL COtlc = 0.58 + 0.42 VA/VAtlc, KCO/KCOtlc = 0.42 + 0.58/(VA/VAtlc). DLCO and KCO were evaluated in 2313 patients. Subgroups of patients with asthma, emphysema, extrapulmonary lung disease, interstitial lung disease and lung resection were identified. Unadjusted DLCO and KCO percent predicted values showed large differences and much variability, so can be misleading. As expected, KCO and DLCO percent predicted values adjusted for alveolar volume were nearly identical. Subgroups have characteristic patterns of VA and unadjusted and adjusted DLCO and KCO. Changes in DLCO and KCO with alveolar volume are relevant for accurate interpretation of diffusion in patients with low lung volumes. Adjusting predicted DLCO and KCO for alveolar volume provides a better assessment of lung function.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10714476     DOI: 10.1053/rmed.1999.0740

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  18 in total

1.  Mechanisms behind inter-individual differences in lung diffusing capacity.

Authors:  G Miserocchi; G Messinesi; F Tana; E Passoni; S Adamo; R Romano; E Beretta
Journal:  Eur J Appl Physiol       Date:  2007-12-04       Impact factor: 3.078

2.  Interpretation of pulmonary function test: issues and controversies.

Authors:  Cristine E Berry; Robert A Wise
Journal:  Clin Rev Allergy Immunol       Date:  2009-03-21       Impact factor: 8.667

3.  ARTP statement on pulmonary function testing 2020.

Authors:  Karl Peter Sylvester; Nigel Clayton; Ian Cliff; Michael Hepple; Adrian Kendrick; Jane Kirkby; Martin Miller; Alan Moore; Gerrard Francis Rafferty; Liam O'Reilly; Joanna Shakespeare; Laurie Smith; Trefor Watts; Martyn Bucknall; Keith Butterfield
Journal:  BMJ Open Respir Res       Date:  2020-07

4.  The Corseted Alveolus.

Authors:  Lucian T Marts; Bashar S Staitieh
Journal:  Ann Am Thorac Soc       Date:  2019-01

5.  Lung function before and after pediatric allogeneic hematopoietic stem cell transplantation: a predictive role for DLCOa/VA.

Authors:  Troy C Quigg; Young-Jee Kim; W Scott Goebel; Paul R Haut
Journal:  J Pediatr Hematol Oncol       Date:  2012-05       Impact factor: 1.289

Review 6.  Assessment of inhibited alveolar-capillary membrane structural development and function in bronchopulmonary dysplasia.

Authors:  Shawn K Ahlfeld; Simon J Conway
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2014-03-06

7.  DLCO: adjust for lung volume, standardised reporting and interpretation.

Authors:  Douglas C Johnson
Journal:  Eur Respir J       Date:  2017-08-24       Impact factor: 16.671

8.  The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment.

Authors:  Jay H Ryu; Joel Moss; Gerald J Beck; Jar-Chi Lee; Kevin K Brown; Jeffrey T Chapman; Geraldine A Finlay; Eric J Olson; Stephen J Ruoss; Janet R Maurer; Thomas A Raffin; Hannah H Peavy; Kevin McCarthy; Angelo Taveira-Dasilva; Francis X McCormack; Nilo A Avila; Rosamma M Decastro; Susan S Jacobs; Mario Stylianou; Barry L Fanburg
Journal:  Am J Respir Crit Care Med       Date:  2005-10-06       Impact factor: 21.405

9.  Carbon monoxide diffusion capacity: how low can you go for hematopoietic cell transplantation eligibility?

Authors:  Jason W Chien; Keith M Sullivan
Journal:  Biol Blood Marrow Transplant       Date:  2009-04       Impact factor: 5.742

10.  Lung transplantation in the management of patients with lymphangioleiomyomatosis: baseline data from the NHLBI LAM Registry.

Authors:  Janet R Maurer; Jay Ryu; Gerald Beck; Joel Moss; Jar-Chi Lee; Geraldine Finlay; Kevin Brown; Jeffrey Chapman; June McMahan; Eric Olson; Stephen Ruoss; Susan Sherer
Journal:  J Heart Lung Transplant       Date:  2007-12       Impact factor: 10.247

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.